Skip to main content

Table 2 Comparison of symptom prevalence (defined as the proportion of severity ratings > 0) using ESAS-ma in 2013 versus ESAS-rb in 2017

From: A comparison of the prevalence of dry mouth and other symptoms using two different versions of the Edmonton Symptom Assessment System on an inpatient palliative care unit

Symptoms

Symptom prevalence, % (n/N)

 

ESAS-ma

(N = 184)

ESAS-rb

(N = 156)

p-value

Items listed similarly in both versions

   

Tiredness

93 (170/182)

99 (151/153)

p = .02

Nausea

49 (90/182)

45 (69/154)

p = .40

Lack of appetite

85 (153/180)

88 (135/153)

p = .39

Shortness of breath

75 (136/181)

79 (21/154)

p = .46

Anxious

75 (136/182)

68 (100/147)

p = .18

Depressed

80 (141/177)

74 (115/151)

p = .45

Wellbeing

88 (152/173)

93 (125/135)

p = .17

Items mentioned in both versions but in different ways

   

Pain at restc

72 (131/182)

 

p = .04

Pain on movementc

83 (149/180)

 

p = .74

Painc

 

81 (127/156)

 

Constipationd

73 (129/176)

15 (24/156)b

p < .001

Items listed in only one version

   

Dry mouthe

83 (151/183)

3 (5/156)c

p < .001

Sleep problemse

71 (126/178)

< 1 (1/156)c

p < .001

Drowsinessf

 

95 (147/155)

n/a

  1. a ESAS-m is a modified version of the original Edmonton Symptom Assessment Scale (ESAS) in use at the palliative care unit in 2013 and included 12 items as described in this table. b ESAS-r is the revised version of the original ESAS in use at the palliative care unit in 2017 and included 10 items as described in this table. c The pain at rest and pain on movement items in the ESAS-m were replaced by a single pain item in the ESAS-r. Each of the ESAS-m pain items was compared to the ESAS-r pain item. d Constipation was not systematically assessed in the ESAS-r, but was given as an example of an “Other problem” and some patients reported it. e Dry mouth and sleep problems were not mentioned in the ESAS-r, but a few patients reported them as an “Other problem”. f Drowsiness was omitted from the ESAS-m, but was included in the ESAS-r. Because the ESAS-m did not allow for additional symptoms to be written in, its prevalence using the ESAS-m could not be determined.